In addition to the survey, a dedicated panel discussion was organized during the ICPerMed Workshop in January 2023.
Barriers were identified in eight categories:
- PM pre-clinical and clinical research settings;
- Patients and citizens involvement;
- Implementation of results;
- Ethical, legal and social aspects;
- Data management;
- Health economics;
- Health technology assessment; and
- European research infrastructures.
The derived recommendations to overcome the obstacles encountered will further be considered in the European Partnership for Personalised Medicine (EP PerMed), and will aid the different stakeholders involved in the integration of PM into the healthcare.
